Joan edukira
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Aurreratua
  • Acarbose was effective in main...
  • Erreferentzia bihurtu
  • SMS
  • Bidali
  • Imprimir
  • Erregistroa esportatu
    • Nora RefWorks
    • Nora EndNoteWeb
    • Nora EndNote
  • Permanent link
Acarbose was effective in maintaining glycemic control in type 2 diabetes mellitus but was associated with adverse effects

Acarbose was effective in maintaining glycemic control in type 2 diabetes mellitus but was associated with adverse effects

Xehetasun bibliografikoak
Egile Nagusiak: Holman, R, Dinneen, S
Formatua: Journal article
Hizkuntza:English
Argitaratua: 1999
  • Aleari buruzko argibideak
  • Deskribapena
  • Antzeko izenburuak
  • MARC erregistroa

Antzeko izenburuak

  • The effect of combination therapy of sulfonylurea, metformin, and acarbose in type 2 diabetes mellitus patients
    nork: Tri Murti Andayani,, et al.
    Argitaratua: (2009-12-01)
  • A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)
    nork: Holman, R, et al.
    Argitaratua: (1999)
  • Effects of the addition of acarbose to insulin and non-insulin regimens in veterans with type 2 diabetes mellitus
    nork: Wettergreen SA, et al.
    Argitaratua: (2016-12-01)
  • Improved glycemic control by acarbose therapy in hypertensive diabetic patients: effects on blood pressure and hormonal parameters
    nork: P. Rosenbaum, et al.
    Argitaratua: (2002-08-01)
  • Impact of baseline characteristics on glycemic effects of add‐on saxagliptin or acarbose to metformin therapy: Subgroup analysis of the SMART study in Chinese patients with type 2 diabetes mellitus
    nork: Hui Fang, et al.
    Argitaratua: (2020-07-01)

Bilaketa aukerak

  • Bilaketaren historia
  • Bilaketa aurreratua

Gehiago bilatu

  • Katalogoa arakatu
  • Bilaketa alfabetikoki
  • Esploratu kanalak
  • Erreserba egin ezazu
  • Berriak liburutegietan

Laguntza behar al duzu?

  • Bilaketa egiteko aholkuak
  • Galdetu liburuzainari
  • FAQ